Your browser doesn't support javascript.
Insight into Genetic Characteristics of Identified SARS-CoV-2 Variants in Egypt from March 2020 to May 2021.
Roshdy, Wael H; Kandeil, Ahmed; El-Shesheny, Rabeh; Khalifa, Mohamed K; Al-Karmalawy, Ahmed A; Showky, Shymaa; Naguib, Amel; Elguindy, Nancy; Fahim, Manal; Abu Elsood, Hanaa; El Taweel, Ahmed; Salamony, Azza; Mohsen, Amira; Kayali, Ghazi; Ali, Mohamed A; Kandeel, Amr.
  • Roshdy WH; Central Public Health Laboratory, Ministry of Health and Population, Cairo 11613, Egypt.
  • Kandeil A; Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt.
  • El-Shesheny R; Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt.
  • Khalifa MK; Central Public Health Laboratory, Ministry of Health and Population, Cairo 11613, Egypt.
  • Al-Karmalawy AA; Department of Pharmaceutical Medicinal Chemistry, Faculty of Pharmacy, Horus University-Egypt, New Damietta 34518, Egypt.
  • Showky S; Central Public Health Laboratory, Ministry of Health and Population, Cairo 11613, Egypt.
  • Naguib A; Central Public Health Laboratory, Ministry of Health and Population, Cairo 11613, Egypt.
  • Elguindy N; Central Public Health Laboratory, Ministry of Health and Population, Cairo 11613, Egypt.
  • Fahim M; Department of Surveillance and Epidemiology, Ministry of Health and Population, Cairo 11613, Egypt.
  • Abu Elsood H; Department of Surveillance and Epidemiology, Ministry of Health and Population, Cairo 11613, Egypt.
  • El Taweel A; Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt.
  • Salamony A; Central Public Health Laboratory, Ministry of Health and Population, Cairo 11613, Egypt.
  • Mohsen A; Egypt Country Office, World Health Organization, Cairo 11613, Egypt.
  • Kayali G; Human Link, Dubai 48800, United Arab Emirates.
  • Ali MA; Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt.
  • Kandeel A; Preventive Sector, Ministry of Health and Population, Cairo 11613, Egypt.
Pathogens ; 11(8)2022 Jul 26.
Article in English | MEDLINE | ID: covidwho-1957410
ABSTRACT
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was first detected in Egypt in February 2020. Data about the prevalence rates of the SARS-CoV-2 lineages are relatively scarce. To understand the genetic characteristics of SARS-CoV-2 in Egypt during several waves of the pandemic, we analyzed sequences of 1256 Egyptian SARS-CoV-2 full genomes from March 2020 to May 2021. From one wave to the next, dominant strains have been observed to be replaced by other dominant strains. We detected an emerging lineage of SARS-CoV-2 in Egypt that shares mutations with the variant of concern (VOC). The neutralizing capacity of sera collected from cases infected with C.36.3 against dominant strains detected in Egypt showed a higher cross reactivity of sera with C.36.3 compared to other strains. Using in silico tools, mutations in the spike of SARS-CoV-2 induced a difference in binding affinity to the viral receptor. The C.36 lineage is the most dominant SARS-CoV-2 lineage in Egypt, and the heterotrophic antigenicity of SARS-CoV-2 variants is asymmetric. These results highlight the value of genetic and antigenic analyses of circulating strains in regions where published sequences are limited.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study / Randomized controlled trials Topics: Variants Language: English Year: 2022 Document Type: Article Affiliation country: Pathogens11080834

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study / Randomized controlled trials Topics: Variants Language: English Year: 2022 Document Type: Article Affiliation country: Pathogens11080834